Leishmania Parasite Quantification by Bioluminescence in Murine Models

Area of Science:

• Parasitology
• Infectious Diseases
• Biomedical Imaging

Background:

• Leishmaniasis is a significant global health concern, affecting millions and posing a risk to hundreds of millions.
• Murine models are essential for studying host-pathogen interactions and developing treatments for leishmaniasis.
• Preclinical imaging is vital for monitoring disease progression and evaluating therapeutic interventions.

Purpose of the Study:

• To establish a high-throughput bioluminescence imaging protocol for quantifying parasite burden in vivo.
• To provide a standardized workflow for data acquisition and analysis in leishmaniasis mouse models.
• To facilitate the assessment of anti-leishmanial drug efficacy in preclinical settings.

Main Methods:

• Development of a high-throughput imaging workflow for bioluminescence detection.
• Standardized protocols for in vivo data acquisition in mouse models.
• Establishment of robust data analysis methods for parasite load quantification.

Main Results:

• The described workflow enables efficient and accurate quantification of parasite burden in leishmaniasis models.
• High-throughput imaging allows for rapid assessment of disease status and treatment response.
• The protocol is optimized for reproducibility and scalability in preclinical research.

Conclusions:

• Bioluminescence in vivo imaging offers a powerful tool for monitoring leishmaniasis progression in mouse models.
• This high-throughput workflow streamlines parasite burden assessment, aiding drug discovery and development.
• The protocol supports a deeper understanding of leishmaniasis pathogenesis and host-parasite interactions.